IMMUNOGENICITY OF INFLIXIMAB AMONG PATIENTS WITH BEHCET'S SYNDROME: A CONTROLLED STUDY
dc.contributor.author | Hatemi, G. | |
dc.contributor.author | Hamuryudan, V. | |
dc.contributor.author | Cevirgen, D. | |
dc.contributor.author | Ozbakir, F. | |
dc.contributor.author | Nohut, O. K. | |
dc.contributor.author | Ozguler, Y. | |
dc.contributor.author | Celik, A. F. | |
dc.contributor.author | Akkoc, F. N. | |
dc.contributor.author | Esatoglu, S. N. | |
dc.contributor.author | Hatemi, I. | |
dc.contributor.author | Yazici, H. | |
dc.date.accessioned | 2021-03-05T11:47:10Z | |
dc.date.available | 2021-03-05T11:47:10Z | |
dc.identifier.citation | Esatoglu S. N. , Akkoc F. N. , Ozguler Y., Ozbakir F., Nohut O. K. , Cevirgen D., Hamuryudan V., Hatemi I., Celik A. F. , Yazici H., et al., "IMMUNOGENICITY OF INFLIXIMAB AMONG PATIENTS WITH BEHCET'S SYNDROME: A CONTROLLED STUDY", Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.767 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_a9e7560d-8a91-4217-b74e-cd4159e3a4f4 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/113462 | |
dc.identifier.uri | https://doi.org/10.1136/annrheumdis-2018-eular.4777 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | IMMUNOGENICITY OF INFLIXIMAB AMONG PATIENTS WITH BEHCET'S SYNDROME: A CONTROLLED STUDY | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 77 | |
dc.contributor.firstauthorID | 153644 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Bildiri [64839]